Biologic response modifiers in the treatment of gastrointestinal malignancies.
Mellstedt
H
H
Dept. of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.
Frödin
J E
JE
Lindemalm
C
C
Masucci
G
G
Merk
K
K
Pettersson
D
D
Ragnhammar
P
P
Steinitz
M
M
Wedelin
C
C
Wersäll
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001685:Biological Factors / Q000627:therapeutic use; D016207:Cytokines; D005770:Gastrointestinal Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D006801:Humans; D011379:Prognosis
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D001685:Biological Factors; D016207:Cytokines